Patient data and images have always lived in separate worlds, but those days are over. Carestream’s Vue Archive and Vue Cloud Archive equip healthcare providers to collect images and data from a variety of information systems, deliver easy integration with any vendor’s EMR (electronic medical records), and offer advanced encryption and security measures, including 24/7 monitoring.

Intelerad Medical Systems announced that the Intelerad Meaningful Use Module 2012 has achieved 2011/2012 Complete EHR (electronic health record) ONC-ATCB Certification, which designates that the software is capable of supporting providers with Stage 1 meaningful use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).

May 30, 2012 — Bayer Radiology & Interventional will showcase new device technologies at the annual meeting of the Society of Nuclear Medicine (SNM) in Miami, June 9-13. The new technology includes enhancements to the Intego PET (positron emission tomography) Infusion System.

May 29. 2012 — Viatronix Inc., developer of 2-D/3-D medical imaging and diagnostic software, announced that its V3D-Colon platform was exclusively used to perform a key study recently published in the Annals of Internal Medicine. The purpose of the study was to determine the feasibility of a laxative-free bowel prep for patients undergoing a virtual colonoscopy (VC) screening exam. The trial utilized a modified version of the Viatronix V3D-Colon software.

May 24, 2012 — Avaxia Biologics Inc., a privately held biotechnology company developing oral antibody drugs that act locally within the gastrointestinal tract, announced this week that the company was awarded U.S. Patent 8,182,818, entitled "Methods of Using Anti-TNF Antibodies for Treating Radiation Damage to the Digestive Tract."

May 24, 2012 — A team of radiologist physicians, ultrasonographers and radiologic technologists will provide a series of didactic and hands-on medical imaging training sessions for local healthcare providers June 4-5 at Grace Children’s Hospital in Port-au-Prince, Haiti.

May 23, 2012 — Magnetic resonance imaging (MRI) provides an indication of a breast tumor's response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online in the journal Radiology.

May 22, 2012 — Peter B. Bach, M.D., of the Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted a systematic review to examine the evidence regarding the benefits and harms of low-dose computerized tomography (LDCT) screening for lung cancer, which is the leading cause of cancer death. "Most patients are diagnosed with advanced disease, resulting in a very low 5-year survival rate," the authors write. "Renewed enthusiasm for lung screening arose with the advent of LDCT imaging, which is able to identify smaller nodules than can chest radiographs."